Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01558 HEC CJ PHARM
RTNominal up12.500 +0.420 (+3.477%)
Others

04/11/2019 14:53

HEC Pharm (01558) signs strategic cooperation agreement

[ET Net News Agency, 4 November 2019] YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
(01558) said it entered into a strategic cooperation framework agreement with Jointown
Pharmaceutical Group Co., Ltd. (Jointown Pharmaceutical).
It authorised Jointown Pharmaceutical as the exclusive general distribution agent for
its products of three separate standards for oseltamivir phosphate (Kewei) and other
pharmaceuticals (subject to further negotiation between the parties) to be sold through
the OTC channel(s) within the PRC. The term of cooperation is for three years.
Jointown Pharmaceutical is a company whose shares are listed on the Shanghai Stock
Exchange (Stock Code: 600998) and principally engages in the business of pharmaceutical
distribution in the PRC. (RC)

Remark: Real time quote last updated: 25/04/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.